
Valink presents at Curious2024 Ignite Session
May 18, 2021
Oxford University Innovation and LiliumX have completed the technology transfer process, establishing LiliumX as a University of Oxford spin-out. LiliumX is spun out from the Department of Biochemistry, and it is the first company in 24 years to be formed solely from this Department. As part of the spin-out process, LiliumX is licensing world-class protein conjugation technologies from Oxford University Innovation, including the SpyTag/SpyCatcher system. LiliumX is proud to be a part of the University's high-profile portfolio, and LiliumX's founders thank the Department of Biochemistry and Oxford University Innovation for their support and fruitful collaboration. Oxford University Innovation's spin-out portfolio can be found here.
More News
Contact us
Valink Therapeutics Inc
One Broadway,
Cambridge,
Massachusetts,
02142
Valink Therapeutics Ltd
Imperial I-Hub,
84 Wood Lane,
London,
W12 0BZ
Design & built by The Sourdough